Page last updated: 2024-11-05

isobutyronitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Isobutyronitrile, also known as 2-methylpropanenitrile, is a colorless liquid with a pungent odor. It is synthesized through the dehydration of isobutyramide or by the reaction of isobutyl alcohol with hydrogen cyanide. Isobutyronitrile is used as an intermediate in the production of various chemicals, including pharmaceuticals, pesticides, and resins. It is also used as a solvent and as a starting material in organic synthesis. Isobutyronitrile is a valuable reagent in organic synthesis, particularly in the preparation of amides, amines, and carboxylic acids. Its importance arises from its ability to undergo nucleophilic substitution reactions and its versatility in various synthetic pathways. The study of isobutyronitrile encompasses its chemical properties, reactivity, and applications in various fields, contributing to advancements in organic synthesis and chemical engineering.'

isobutyronitrile : An aliphatic nitrile that is acetonitrile in which two of the hydrogens have been replaced by methyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6559
CHEMBL ID1492874
CHEBI ID28638
MeSH IDM0078029

Synonyms (68)

Synonym
2-methylpropane nitrile
brn 1340512
un2284
einecs 201-147-5
isopropyl nitrile
hsdb 5221
propanoic acid, 2-methyl-, nitrile
alpha-methylpropanenitrile
ai3-28525
isopropylkyanid [czech]
nsc 60536
1-cyano-1-methylethane
nsc-60536
nsc60536
dimethylacetonitrile
isopropyl cyanide
wln: ncy1&1
2-methylpropionitrile
isopropylnitrile
2-cyanopropane
inchi=1/c4h7n/c1-4(2)3-5/h4h,1-2h
propanenitrile, 2-methyl-
NCGC00091769-01
2-methylpropanenitrile
78-82-0
isobutyronitrile
C02420
isobutyronitrile, 99.6%
isobutyronitrile, 99%
I0112
AKOS000119968
NCGC00091769-02
dtxsid5026461 ,
dtxcid606461
cas-78-82-0
NCGC00257156-01
tox21_303042
NCGC00259478-01
tox21_201929
isobutyronitrile [un2284] [flammable liquid]
699awf2wv2 ,
4-02-00-00853 (beilstein handbook reference)
isopropylkyanid
unii-699awf2wv2
ccris 9442
isobutyronitrile [mi]
isobutanenitrile
.alpha.-methylpropanenitrile
un-2284
propanenitrile,2-methyl-
CHEMBL1492874
iso butyro nitrile
(ch3)2chcn
2-methyl-propanenitrile
2-propylcyanide
2-methyl-propionitrile
iso-butyronitrile
un 2284
iso-c3h7cn
mfcd00001873
J-510084
F0001-2057
CHEBI:28638
Q1960244
174736-88-0
EN300-19661
isopropyl-d6nitrile
2-methylpropanenitrile, isopropyl cyanide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
polar aprotic solventA solvent with a comparatively high relative permittivity (or dielectric constant), greater than ca. 15, and a sizable permanent dipole moment, that cannot donate suitably labile hydrogen atoms to form strong hydrogen bonds.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
aliphatic nitrileAny nitrile derived from an aliphatic compound.
volatile organic compoundAny organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
superpathway of linamarin and lotaustralin biosynthesis123
linamarin biosynthesis115
linamarin biosynthesis015
superpathway of linamarin and lotaustralin biosynthesis023

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thyroid stimulating hormone receptorHomo sapiens (human)Potency7.94330.001318.074339.8107AID926; AID938
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency61.41160.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency16.32190.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency9.26070.000817.505159.3239AID1159527
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency58.43100.001019.414170.9645AID743191
activating transcription factor 6Homo sapiens (human)Potency24.54120.143427.612159.8106AID1159516
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.58960.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency51.31850.000627.21521,122.0200AID651741; AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (17.65)18.7374
1990's0 (0.00)18.2507
2000's6 (35.29)29.6817
2010's7 (41.18)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.84 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index87.61 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]